Patent Archives - NORD (National Organization for Rare Disorders)

New Study Investigates the Number of Available Orphan Products, Generics and Biosimilars

Written by Jennifer Huron on March 25, 2021

Washington, DC, March 25, 2021—The National Organization for Rare Disorders (NORD®) today announced the findings of a new study that details the number of orphan products, generics and biosimilars available to treat rare diseases. NORD commissioned Avalere to conduct the analysis to… Read More

Supreme Court Decision Consistent With Longstanding NORD Position

Written by Mary Dunkle on June 14, 2013

Yesterday’s ruling by the U.S. Supreme Court that human genes are a product of nature and cannot be patented is being hailed by many as a victory for patients and medical research. (more…)

Archives for: March 25th, 2021

New Study Investigates the Number of Available Orphan Products, Generics and Biosimilars

Written by Jennifer Huron on March 25, 2021

Supreme Court Decision Consistent With Longstanding NORD Position

Written by Mary Dunkle on June 14, 2013

Alone we are rare. Together we are strong.®